Circulating Secretory Phospholipase A2 Activity Predicts Recurrent Events in Patients With Severe Acute Coronary Syndromes
- 4 October 2005
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 46 (7), 1249-1257
- https://doi.org/10.1016/j.jacc.2005.06.056
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Determinants and Prognostic Impact of Heart Failure Complicating Acute Coronary SyndromesCirculation, 2004
- Prognostic value and the changes of plasma levels of secretory type II phospholipase A2 in patients with coronary artery disease undergoing percutaneous coronary interventionPublished by Oxford University Press (OUP) ,2003
- Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE)**Further information about the project, along with a complete list of the study participants, can be found at www.outcomes.org/grace.The American Journal of Cardiology, 2002
- Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: A multinational registry of patients hospitalized with acute coronary syndromesAmerican Heart Journal, 2001
- Prognostic value of plasma levels of secretory type II phospholipase A2 in patients with unstable angina pectorisThe American Journal of Cardiology, 2000
- Circulating Levels of Secretory Type II Phospholipase A 2 Predict Coronary Events in Patients with Coronary Artery DiseaseCirculation, 1999
- Role of Group II Secretory Phospholipase A2in AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Expression of Phospholipase A 2 Isoforms in Human Normal and Atherosclerotic Arterial WallArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Type II phospholipase A2 recombinant overexpression enhances stimulated arachidonic acid releaseBiochemical and Biophysical Research Communications, 1991
- A sensitive and continuous fluorometric assay for phospholipase A2 using pyrene-labeled phospholipids in the presence of serum albuminAnalytical Biochemistry, 1989